Intravenous tenecteplase shows no benefit in minor ischaemic stroke with intracranial occlusion
Physician's Weekly,
1. Return to baseline function was comparable in tenecteplase and standard-of-care groups. 2. More deaths and intracranial…
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
Overview of attention for article published in The Lancet, May 2024
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (93rd percentile)
Mentioned by
- news
- 29 news outlets
- blogs
- 1 blog
- 92 X users
- patent
- 1 patent
- 1 Facebook page
- 1 Redditor
- video
- 1 YouTube creator
- podcasts
- 3 podcasts
Readers on
- mendeley
- 115 Mendeley